Long-term efficacy of everolimus as de novo immunosuppressant on the cardiac allograft vasculopathy in heart transplant recipients

Author:

Choi Hyo-InORCID,Kang Do-Yoon,Kim Min-Seok,Lee Sang Eun,Ahn Jung-Min,Lee Jong-Young,Kim Yong-Hak,Park Duk-Woo,Jung Sung-Ho,Kim Jae-JoongORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. The international thoracic organ transplant registry of the international society for heart and Lung transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics;Khush;J. Heart Lung Transplant.,2020

2. Cardiac allograft vasculopathy: current review and future research directions;Pober;Cardiovasc. Res.,2021

3. Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy;Mallah;Prog. Cardiovasc. Dis.,2020

4. Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial;Eisen;Am. J. Transplant.,2013

5. Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the everolimus versus mycophenolate mofetil randomized, multicenter trial;Kobashigawa;JACC: Heart Fail.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3